CM
AMED

Caption Management’s Amedisys AMED Stock Holding History

Caption Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200,000
Closed -$18.2M – 1473
2024
Q4 		$18.2M Buy
200,000
+150,000
+300% +$13.8M 0.17% 93
2024
Q3 		$4.83M Hold
50,000
– – 0.08% 304
2024
Q2 		$4.59M Hold
50,000
– – 0.07% 275
2024
Q1 		$4.61M Hold
50,000
– – 0.07% 312
2023
Q4 		$4.75M Buy
+50,000
New +$4.67M 0.06% 353

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's AMED Position: Q4 2021 in Review

Caption Management sold out of Amedisys (AMED) in Q4 2021, closing a stake of 10,000 shares — an estimated $1.49M sold.

Caption Management first reported a position in AMED in Q1 2021 and held it in 3 quarters. The position peaked at $1.49M in Q3 2021. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Caption Management reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Caption Management sold 10,000 Amedisys shares in Q4 2021, an estimated $1.49M.
  • Caption Management first reported a position in Amedisys in Q1 2021 and held it in 3 quarters.
  • Caption Management's Amedisys position peaked at $1.49M in Q3 2021.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.